P2C PHARMA LTD - READING
| Company Profile | Company Filings |
Overview
P2C PHARMA LTD is a Private Limited Company from READING UNITED KINGDOM and has the status: Active.
P2C PHARMA LTD was incorporated 5 years ago on 26/07/2018 and has the registered number: 11485980. The accounts status is MICRO ENTITY and accounts are next due on 30/04/2025.
P2C PHARMA LTD was incorporated 5 years ago on 26/07/2018 and has the registered number: 11485980. The accounts status is MICRO ENTITY and accounts are next due on 30/04/2025.
P2C PHARMA LTD - READING
This company is listed in the following categories:
70229 - Management consultancy activities other than financial management
70229 - Management consultancy activities other than financial management
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 7 | 31/07/2023 | 30/04/2025 |
Registered Office
STARCOURT THAMES STREET
READING
RG4 6UR
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 25/07/2023 | 08/08/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| DR MARK HENRY SAUNDERS | Sep 1976 | British | Director | 2018-07-26 | CURRENT |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Dr Mark Henry Saunders | 2018-07-26 | 9/1976 | Reading |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| Accounts Submission | 2024-01-24 | 31-07-2023 | £788,126 equity |
| Accounts Submission | 2022-08-26 | 31-07-2022 | £480,322 equity |
| Accounts Submission | 2021-08-04 | 31-07-2021 | £229,342 equity |
| Accounts Submission | 2020-08-05 | 31-07-2020 | £64,236 equity |
| Micro-entity Accounts - P2C PHARMA LTD | 2019-08-21 | 31-07-2019 | £933 equity |